MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$18,900K
(-34.04%↓ Y/Y)
Net loss
-$18,899K
(-34.14%↓ Y/Y)
Unrealized loss (gain) on
marketable securities
-$1K
(90.91%↑ Y/Y)
Loss before income
taxes
-$18,899K
(-34.14%↓ Y/Y)
Interest income, net
$647K
(-37.25%↓ Y/Y)
Loss from operations
-$19,546K
(-29.27%↓ Y/Y)
Total revenues
$303K
(29.49%↑ Y/Y)
Total operating
expenses
$19,849K
(29.28%↑ Y/Y)
Research and development
$14,223K
(25.81%↑ Y/Y)
General and
administrative
$5,626K
(38.95%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. (VTGN)